Reference
Olszewski AJ, et al. Subsidies for Oral Chemotherapy and Use of Immunomodulatory Drugs Among Medicare Beneficiaries With Myeloma. Journal of Clinical Oncology : JCO2017722447, 25 May 2017. Available from: URL: http://doi.org/10.1200/JCO.2017.72.2447
Rights and permissions
About this article
Cite this article
IMiD use affected by LIS receipt in US beneficiaries with myeloma. PharmacoEcon Outcomes News 780, 22 (2017). https://doi.org/10.1007/s40274-017-4074-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4074-9